Matthew J Hepburn
Overview
Explore the profile of Matthew J Hepburn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
569
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dyson E, Simpson A, Gwyther R, Cuthbertson H, Patient D, Matheson M, et al.
Vaccine
. 2022 Sep;
40(42):6163-6178.
PMID: 36153153
We undertook a Phase 4 clinical trial to assess the effect of time interval between booster doses on serological responses to AVP. The primary objective was to evaluate responses to...
2.
Paquin-Proulx D, Gunn B, Alrubayyi A, Clark D, Creegan M, Kim D, et al.
Front Immunol
. 2021 Jun;
12:682120.
PMID: 34093585
Antibodies that mediate non-neutralizing functions play an important role in the immune response to Ebola virus (EBOV) and are thought to impact disease outcome. EBOV has also been associated with...
3.
Akhvlediani T, Bautista C, Garuchava N, Sanodze L, Kokaia N, Malania L, et al.
PLoS One
. 2017 Jan;
12(1):e0170376.
PMID: 28107444
Background: Brucellosis is an endemic disease in the country of Georgia. According to the National Center for Disease Control and Public Health of Georgia (NCDC), the average annual number of...
4.
Laws T, Kuchuloria T, Chitadze N, Little S, Webster W, Debes A, et al.
PLoS One
. 2016 Mar;
11(3):e0148713.
PMID: 27007118
Several different human vaccines are available to protect against anthrax. We compared the human adaptive immune responses generated by three different anthrax vaccines or by previous exposure to cutaneous anthrax....
5.
Zamisch M, Hepburn M, Ling G
Mil Med
. 2016 Mar;
181(3):195-7.
PMID: 26926740
No abstract available.
6.
Kuchuloria T, Imnadze P, Mamuchishvili N, Chokheli M, Tsertsvadze T, Endeladze M, et al.
Am J Trop Med Hyg
. 2015 Oct;
94(1):236-42.
PMID: 26438032
Information on the infectious causes of undifferentiated acute febrile illness (AFI) in Georgia is essential for effective treatment and prevention. In May 2008, a hospital-based AFI surveillance was initiated at...
7.
Chang J, Holloway B, Zamisch M, Hepburn M, Ling G
Mil Med
. 2015 Sep;
180(9):932-3.
PMID: 26327542
Noncompressible torso hemorrhage is the leading cause of potentially survivable death on the battlefield. While medical advances have decreased the rate of "died of wounds" to less than 5%, significant...
8.
Sanodze L, Bautista C, Garuchava N, Chubinidze S, Tsertsvadze E, Broladze M, et al.
BMC Public Health
. 2015 May;
15:459.
PMID: 25934639
Background: Brucellosis is considered as endemic zoonotic disease in the country of Georgia. However, the burden of the disease on a household level is not known. Therefore, this study sought...
9.
Clark D, Kibuuka H, Millard M, Wakabi S, Lukwago L, Taylor A, et al.
Lancet Infect Dis
. 2015 Apr;
15(8):905-12.
PMID: 25910637
Background: The limited data available for long-term Ebola virus disease health outcomes suggest that sequelae persist for longer than 1 year after infection. The magnitude of the present outbreak in...
10.
Kuchuloria T, Imnadze P, Chokheli M, Tsertsvadze T, Endeladze M, Mshvidobadze K, et al.
Am J Trop Med Hyg
. 2014 Jun;
91(2):246-8.
PMID: 24891463
Minimal information is available on the incidence of Crimean-Congo hemorrhagic fever (CCHF) virus and hantavirus infections in Georgia. From 2008 to 2011, 537 patients with fever ≥ 38°C for ≥...